Inhaled atrial natriuretic peptide and asthmatic airways.

BMJ

Department of Respiratory Medicine, Western Infirmary, Glasgow.

Published: May 1992

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1882083PMC
http://dx.doi.org/10.1136/bmj.304.6835.1156DOI Listing

Publication Analysis

Top Keywords

inhaled atrial
4
atrial natriuretic
4
natriuretic peptide
4
peptide asthmatic
4
asthmatic airways
4
inhaled
1
natriuretic
1
peptide
1
asthmatic
1
airways
1

Similar Publications

Background: Women with endometriosis are more likely to have migraine. The mechanisms underlying this co-morbidity are unknown. Prolactin, a neurohormone secreted and released into circulation from the anterior pituitary, can sensitize sensory neurons from female, but not male, rodents, monkeys and human donors.

View Article and Find Full Text PDF

Objective: To summarize anesthetic and perioperative considerations in patients undergoing the convergent procedure for atrial fibrillation (AF).

Design: Retrospective observational study.

Setting: A single quaternary teaching hospital.

View Article and Find Full Text PDF

Inhaled substance use and cardiac ectopy.

Heart Rhythm

November 2024

Division of Cardiology, Electrophysiology Section, Department of Medicine, University of California, San Francisco, San Francisco, California. Electronic address:

View Article and Find Full Text PDF

Background: Volatile substance (thinner) addiction can cause serious cardiac events, such as malignant ventricular arrhythmias, acute coronary syndromes, sudden death syndrome, and dilated cardiomyopathy, as reported in many case studies. We aimed to find echocardiographic and electrocardiographic parameters that could foresee these adverse outcomes in clinical settings.

Methods: We enrolled 32 healthy young adult patients with at least 1 year of thinner addiction and no cardiac symptoms.

View Article and Find Full Text PDF

An analysis of the safety of Sevoflurane drugs: A disproportionality analysis based on Food and Drug Administration Adverse Event Reporting System.

Medicine (Baltimore)

August 2024

Department of Anesthesiology, The Affiliated Lihuili Hospital, Ningbo University, Ningbo, Zhejiang Province, P. R. China.

Sevoflurane is a volatile anesthetic that can tolerate inhalation induction and is widely used for inducing anesthesia due to its pleasant odor. As a drug that has been on the market for nearly 30 years, the vast majority of adverse reactions have been documented. This study aims to improve the adverse reactions related to Sevoflurane through the mining, organizing and analysis of Food and Drug Administration Adverse Event Reporting System database data.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!